Previous close | 966.30 |
Open | 970.38 |
Bid | 962.09 x 200 |
Ask | 962.99 x 200 |
Day's range | 959.25 - 970.79 |
52-week range | 684.81 - 998.33 |
Volume | |
Avg. volume | 502,129 |
Market cap | 105.645B |
Beta (5Y monthly) | 0.11 |
PE ratio (TTM) | 27.71 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Praxis Precision Medicines, Inc. (PRAX) and Viking Therapeutics, Inc. (VKTX) gain from positive study updates.
Regeneron's (REGN) efforts to expand its oncology portfolio get a hit as the FDA refuses to approve the lymphoma drug odronextamab.
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...